MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation Shares 2011-2026 | DHR
Annual Shares Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 713 M | 731 M | 736 M | 725 M | 715 M | 706 M | 715 M | 701 M | 696 M | 691 M | 698 M | 702 M | 696 M | 693 M | 676 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 736 M | 676 M | 706 M |
Quarterly Shares Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 716 M | 719 M | 741 M | - | - | 727 M | 716 M | 715 M | 715 M | 714 M | 713 M | 711 M | 711 M | 705 M | 697 M | 696 M | 719 M | 718 M | 708 M | 702 M | 701 M | 700 M | 699 M | 697 M | 696 M | 695 M | 694 M | 692 M | 692 M | 691 M | 689 M | 687 M | 688 M | 710 M | 707 M | 704 M | 703 M | 701 M | 700 M | 698 M | 698 M | 695 M | 692 M | 688 M | 695 M | 696 M | 692 M | 688 M | 687 M | 667 M | 662 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 741 M | 662 M | 701 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 17.65 | 3.67 % | $ 186 M |  China |
 |
Agilent Technologies
A
|
304 M | $ 117.92 | 0.31 % | $ 35.8 B |  USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 429.45 | -0.2 % | $ 12.4 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.06 | -19.38 % | $ 376 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 8.81 | -0.56 % | $ 1.13 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
22.4 M | $ 18.23 | -2.72 % | $ 408 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 214.17 | 3.58 % | $ 21.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.04 | 2.23 % | $ 20 B |  Niderland |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
59.3 M | $ 5.98 | 7.55 % | $ 354 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.93 | 0.02 % | $ 2.69 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 20.87 | 0.82 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 471.04 | 0.93 % | $ 178 B | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.61 | 1.26 % | $ 2.14 M | USA |
 |
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.62 | 2.79 % | $ 61.9 M |  Irlanda |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.93 | 1.34 % | $ 692 M | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 59.92 | 5.68 % | $ 3.58 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 184.9 | -0.26 % | $ 9.16 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Waters Corporation
WAT
|
59.5 M | $ 349.35 | 1.92 % | $ 20.8 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.16 | 1.74 % | $ 458 M | USA |
 |
Guardant Health
GH
|
125 M | $ 91.12 | 1.78 % | $ 11.4 B | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 122.9 | 1.3 % | $ 10.1 B | Irlanda |
 |
Illumina
ILMN
|
159 M | $ 140.99 | 1.38 % | $ 22.4 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 5.16 | 3.2 % | $ 215 M | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 2.01 | 0.1 % | $ 8.89 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.3 M | $ 2.2 | 0.51 % | $ 5.05 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 86.08 | 0.3 % | $ 5.81 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 258.55 | 0.55 % | $ 21.5 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 140.36 | -0.94 % | $ 6.56 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.24 | -0.27 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 191.08 | 0.13 % | $ 21.2 B | USA |